Skin tumor development after UV irradiation and photodynamic therapy is unaffected by short-term pretreatment with 5-fluorouracil, imiquimod and calcipotriol: An experimental hairless mouse study

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Skin tumor development after UV irradiation and photodynamic therapy is unaffected by short-term pretreatment with 5-fluorouracil, imiquimod and calcipotriol : An experimental hairless mouse study. / Bay, Christiane; Togsverd-Bo, Katrine; Lerche, Catharina M; Haedersdal, Merete.

I: Journal of Photochemistry and Photobiology, B: Biology, Bind 154, 01.2016, s. 34-39.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Bay, C, Togsverd-Bo, K, Lerche, CM & Haedersdal, M 2016, 'Skin tumor development after UV irradiation and photodynamic therapy is unaffected by short-term pretreatment with 5-fluorouracil, imiquimod and calcipotriol: An experimental hairless mouse study', Journal of Photochemistry and Photobiology, B: Biology, bind 154, s. 34-39. https://doi.org/10.1016/j.jphotobiol.2015.11.009

APA

Bay, C., Togsverd-Bo, K., Lerche, C. M., & Haedersdal, M. (2016). Skin tumor development after UV irradiation and photodynamic therapy is unaffected by short-term pretreatment with 5-fluorouracil, imiquimod and calcipotriol: An experimental hairless mouse study. Journal of Photochemistry and Photobiology, B: Biology, 154, 34-39. https://doi.org/10.1016/j.jphotobiol.2015.11.009

Vancouver

Bay C, Togsverd-Bo K, Lerche CM, Haedersdal M. Skin tumor development after UV irradiation and photodynamic therapy is unaffected by short-term pretreatment with 5-fluorouracil, imiquimod and calcipotriol: An experimental hairless mouse study. Journal of Photochemistry and Photobiology, B: Biology. 2016 jan.;154:34-39. https://doi.org/10.1016/j.jphotobiol.2015.11.009

Author

Bay, Christiane ; Togsverd-Bo, Katrine ; Lerche, Catharina M ; Haedersdal, Merete. / Skin tumor development after UV irradiation and photodynamic therapy is unaffected by short-term pretreatment with 5-fluorouracil, imiquimod and calcipotriol : An experimental hairless mouse study. I: Journal of Photochemistry and Photobiology, B: Biology. 2016 ; Bind 154. s. 34-39.

Bibtex

@article{bea1f250f1c240e691a2425105c9e1a6,
title = "Skin tumor development after UV irradiation and photodynamic therapy is unaffected by short-term pretreatment with 5-fluorouracil, imiquimod and calcipotriol: An experimental hairless mouse study",
abstract = "Background Photodynamic therapy (PDT) delays ultraviolet (UV) radiation-induced squamous cell carcinomas (SCCs) in hairless mice. Efficacy may be enhanced by combining PDT with antineoplastic or pro-differentiating agents. We investigated if pretreatment with 5-fluorouracil (5FU), imiquimod (IMIQ) or calcipotriol (CAL) before PDT further delays tumor onset. Methods Hairless mice (n = 224) were exposed 3 times weekly to 3 standard erythema doses (SED) of UV radiation. Methyl-aminolevulinate (MAL)-PDT sessions were given on days 45 and 90 before SCC development. Three applications of topical 5FU, IMIQ or CAL were given before each PDT session. Fluorescence photography quantified protoporphyrin IX (PpIX) formation. Results PDT delayed UV-induced SCC development by 59 days (212 days UV-MAL-PDT vs. 153 days UV-control, P < 0.001). Pretreatment with 5FU, IMIQ or CAL before PDT did not further delay SCC onset compared to PDT alone (207 days UV-5FU-MAL-PDT, 215 days UV-IMIQ-MAL-PDT, 206 days UV-CAL-MAL-PDT vs. 212 days UV-MAL-PDT, P = ns). PpIX fluorescence intensified by 5FU-pretreatment (median 21,392 au UV-5FU-MAL-PDT, P = 0.011), decreased after IMIQ-pretreatment (12,452 au UV-IMIQ-MAL-PDT, P < 0.001), and was unaffected by CAL-pretreatment (19,567 au UV-CAL-MAL-PDT, P = ns) compared to MAL alone (18,083 au UV-MAL-PDT). Conclusions Short-term three-day pretreatment with 5FU, IMIQ and CAL before PDT does not further delay tumor onset in UV-exposed hairless mice.",
keywords = "Antineoplastic drugs, Hairless mice, Photodynamic therapy, Pretreatment, Protoporphyrin IX",
author = "Christiane Bay and Katrine Togsverd-Bo and Lerche, {Catharina M} and Merete Haedersdal",
year = "2016",
month = jan,
doi = "10.1016/j.jphotobiol.2015.11.009",
language = "English",
volume = "154",
pages = "34--39",
journal = "Journal of Photochemistry and Photobiology B: Biology",
issn = "1011-1344",
publisher = "Elsevier",

}

RIS

TY - JOUR

T1 - Skin tumor development after UV irradiation and photodynamic therapy is unaffected by short-term pretreatment with 5-fluorouracil, imiquimod and calcipotriol

T2 - An experimental hairless mouse study

AU - Bay, Christiane

AU - Togsverd-Bo, Katrine

AU - Lerche, Catharina M

AU - Haedersdal, Merete

PY - 2016/1

Y1 - 2016/1

N2 - Background Photodynamic therapy (PDT) delays ultraviolet (UV) radiation-induced squamous cell carcinomas (SCCs) in hairless mice. Efficacy may be enhanced by combining PDT with antineoplastic or pro-differentiating agents. We investigated if pretreatment with 5-fluorouracil (5FU), imiquimod (IMIQ) or calcipotriol (CAL) before PDT further delays tumor onset. Methods Hairless mice (n = 224) were exposed 3 times weekly to 3 standard erythema doses (SED) of UV radiation. Methyl-aminolevulinate (MAL)-PDT sessions were given on days 45 and 90 before SCC development. Three applications of topical 5FU, IMIQ or CAL were given before each PDT session. Fluorescence photography quantified protoporphyrin IX (PpIX) formation. Results PDT delayed UV-induced SCC development by 59 days (212 days UV-MAL-PDT vs. 153 days UV-control, P < 0.001). Pretreatment with 5FU, IMIQ or CAL before PDT did not further delay SCC onset compared to PDT alone (207 days UV-5FU-MAL-PDT, 215 days UV-IMIQ-MAL-PDT, 206 days UV-CAL-MAL-PDT vs. 212 days UV-MAL-PDT, P = ns). PpIX fluorescence intensified by 5FU-pretreatment (median 21,392 au UV-5FU-MAL-PDT, P = 0.011), decreased after IMIQ-pretreatment (12,452 au UV-IMIQ-MAL-PDT, P < 0.001), and was unaffected by CAL-pretreatment (19,567 au UV-CAL-MAL-PDT, P = ns) compared to MAL alone (18,083 au UV-MAL-PDT). Conclusions Short-term three-day pretreatment with 5FU, IMIQ and CAL before PDT does not further delay tumor onset in UV-exposed hairless mice.

AB - Background Photodynamic therapy (PDT) delays ultraviolet (UV) radiation-induced squamous cell carcinomas (SCCs) in hairless mice. Efficacy may be enhanced by combining PDT with antineoplastic or pro-differentiating agents. We investigated if pretreatment with 5-fluorouracil (5FU), imiquimod (IMIQ) or calcipotriol (CAL) before PDT further delays tumor onset. Methods Hairless mice (n = 224) were exposed 3 times weekly to 3 standard erythema doses (SED) of UV radiation. Methyl-aminolevulinate (MAL)-PDT sessions were given on days 45 and 90 before SCC development. Three applications of topical 5FU, IMIQ or CAL were given before each PDT session. Fluorescence photography quantified protoporphyrin IX (PpIX) formation. Results PDT delayed UV-induced SCC development by 59 days (212 days UV-MAL-PDT vs. 153 days UV-control, P < 0.001). Pretreatment with 5FU, IMIQ or CAL before PDT did not further delay SCC onset compared to PDT alone (207 days UV-5FU-MAL-PDT, 215 days UV-IMIQ-MAL-PDT, 206 days UV-CAL-MAL-PDT vs. 212 days UV-MAL-PDT, P = ns). PpIX fluorescence intensified by 5FU-pretreatment (median 21,392 au UV-5FU-MAL-PDT, P = 0.011), decreased after IMIQ-pretreatment (12,452 au UV-IMIQ-MAL-PDT, P < 0.001), and was unaffected by CAL-pretreatment (19,567 au UV-CAL-MAL-PDT, P = ns) compared to MAL alone (18,083 au UV-MAL-PDT). Conclusions Short-term three-day pretreatment with 5FU, IMIQ and CAL before PDT does not further delay tumor onset in UV-exposed hairless mice.

KW - Antineoplastic drugs

KW - Hairless mice

KW - Photodynamic therapy

KW - Pretreatment

KW - Protoporphyrin IX

U2 - 10.1016/j.jphotobiol.2015.11.009

DO - 10.1016/j.jphotobiol.2015.11.009

M3 - Journal article

C2 - 26678673

AN - SCOPUS:84949517472

VL - 154

SP - 34

EP - 39

JO - Journal of Photochemistry and Photobiology B: Biology

JF - Journal of Photochemistry and Photobiology B: Biology

SN - 1011-1344

ER -

ID: 179217166